Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-079-0 | CAS number: -
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
The following remarks on the toxicokinetics of ITC 288/S are based on physico-chemical properties of the compound and on toxicological data. Experimental toxicokinetic studies were not performed .
Absorption
The low toxicity of the substance when administered orally compared with the greater toxicity when
administered by the intraperitoneal route in the micronucleus study suggests that the substance is poorly
absorbed from the gastro- intestinal tract. The poor lipid solubility of the substance indicates
that dermal absorption will be low.
Distribution
There is no experimental evidence to indicate distribution of any absorbed substance
but the low fat solubility and log Pow value suggest that bioaccumulation is unlikely. The substance was shown to induce contact sensitisation in a guinea pig study so it,
presumably, can become bound to proteins.
Metabolism
An in-vitro chromosome aberration study showed some evidence of increased cytotoxicity
in the presence of S9 (an hepatic metabolising enzyme broth). This may indicate that the substance has potential to be biotransformed by microsomal enzymes but there is no
other experimental evidence to support this.
Excretion
Again, there is no evidence to indicate a route of excretion for this substance but it's water solubility
is such that excretion of unchanged parent substance could occur by biliary or renal routes. Presumably,
any metabolites would be similarly water soluble. In view of the possible potential of the substance
to become protein bound, excretion in the bile might be anticipated. The parent substance could not
be eliminated via the lungs in expired air because it is non-volatile.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
